Startseite UR
Einträge von Scherer, Marcus N. auf dem Publikationsserver
 | Eine Stufe nach oben |
Anzahl der Einträge: 10.
2021
Eggenhofer, Elke, Groell, Anja, Junger, Henrik, Kasi, Amoon, Kroemer, Alexander, Geissler, Edward K., Schlitt, Hans J. 
und Scherer, Marcus N.
(2021)
Steatotic Livers Are More Susceptible to Ischemia Reperfusion Damage after Transplantation and Show Increased γδ T Cell Infiltration.
IJMS 22 (2036), S. 1-12.
2020
Sinner, Barbara, Banas, Miriam, Brunete-Lorenzo, Clara, Zant, Robert, Knoppke, Birgit, Scherer, Marcus N., Graf, Bernhard M. und Lunz, Dirk
(2020)
Acute Kidney Injury and Renal Regional Oxygen Saturation During Pediatric Liver Transplantation.
Annals of Transplantation 25.
Volltext nicht vorhanden.
2019
Herden, Uta, Grabhorn, Enke, Santer, René, Li, Jun, Nadalin, Silvio, Rogiers, Xavier, Scherer, Marcus N., Braun, Felix, Beime, Jan, Lenhartz, Henning, Muntau, Ania C. und Fischer, Lutz
(2019)
Surgical Aspects of Liver Transplantation and Domino Liver Transplantation in Maple Syrup Urine Disease: Analysis of 15 Donor‐Recipient Pairs.
Liver Transplantation 25 (6), S. 889-900.
Volltext nicht vorhanden.
2018
Benck, Urs, Jung, Matthias, Krüger, Bernd, Grimm, Anja, Weiss, Christel, Yard, Benito A., Lehner, Frank, Kiessling, Anja, Fischer, Lutz, Gallinat, Anja, Kleespies, Axel, Lorf, Thomas, Sucher, Robert, Mönch, Christian, Scherer, Marcus N., Rahmel, Axel, Schemmer, Peter, Krämer, Bernhard K. und Schnuelle, Peter
(2018)
Donor Dopamine Does Not Affect Liver Graft Survival: Evidence of Safety From a Randomized Controlled Trial.
Liver Transplantation 24 (10), S. 1336-1345.
Volltext nicht vorhanden.
2012
Bauer, Sabrina, Weiss, Thomas S. , Wiest, Reiner, Schacherer, Doris, Hellerbrand, Claus, Farkas, Stefan, Scherer, Marcus N., Ritter, Mirko, Schmitz, Gerd, Schäffler, Andreas und Buechler, Christa
(2012)
Corrigendum to “Soluble CD163 is not increased in visceral fat and steatotic liver and is even suppressed by free fatty acids in-vitro” [Exp. Mol. Pathol. 91-3 (2011) 733–739].
Experimental and Molecular Pathology 93 (2), S. 283.
Volltext nicht vorhanden.
, Wiest, Reiner, Schacherer, Doris, Hellerbrand, Claus, Farkas, Stefan, Scherer, Marcus N., Ritter, Mirko, Schmitz, Gerd, Schäffler, Andreas und Buechler, Christa
(2012)
Corrigendum to “Soluble CD163 is not increased in visceral fat and steatotic liver and is even suppressed by free fatty acids in-vitro” [Exp. Mol. Pathol. 91-3 (2011) 733–739].
Experimental and Molecular Pathology 93 (2), S. 283.
Volltext nicht vorhanden.
Dillmann, Johannes, Popp, Felix C., Fillenberg, Barbara, Zeman, Florian, Eggenhofer, Elke, Farkas, Stefan, Scherer, Marcus N., Koller, Michael, Geissler, Edward K., Deans, Robert, Ladenheim, Deborah, Loss, Martin, Schlitt, Hans-Jürgen und Dahlke, Marc H.
(2012)
Treatment-emergent adverse events after infusion of adherent stem cells: the MiSOT-I score for solid organ transplantation.
Trials 13, S. 211.
2011
Bauer, Sabrina, Weiss, Thomas S. , Wiest, Reiner, Schacherer, Doris, Hellerbrand, Claus, Farkas, Stefan, Scherer, Marcus N., Ritter, Mirko, Schmitz, Gerd, Schäffler, Andreas und Buechler, Christa
(2011)
Soluble CD163 is not increased in visceral fat and steatotic liver and is even suppressed by free fatty acids in vitro.
Experimental and Molecular Pathology 91 (3), S. 733-739.
Volltext nicht vorhanden.
, Wiest, Reiner, Schacherer, Doris, Hellerbrand, Claus, Farkas, Stefan, Scherer, Marcus N., Ritter, Mirko, Schmitz, Gerd, Schäffler, Andreas und Buechler, Christa
(2011)
Soluble CD163 is not increased in visceral fat and steatotic liver and is even suppressed by free fatty acids in vitro.
Experimental and Molecular Pathology 91 (3), S. 733-739.
Volltext nicht vorhanden.
Wanninger, Josef, Weigert, Johanna, Wiest, Reiner, Bauer, Sabrina, Karrasch, Thomas, Farkas, Stefan, Scherer, Marcus N., Walter, Roland, Weiss, Thomas S. , Hellerbrand, Claus, Neumeier, Markus, Schäffler, Andreas und Buechler, Christa
(2011)
Systemic and hepatic vein galectin-3 are increased in patients with alcoholic liver cirrhosis and negatively correlate with liver function.
Cytokine 55 (3), S. 435-440.
Volltext nicht vorhanden.
, Hellerbrand, Claus, Neumeier, Markus, Schäffler, Andreas und Buechler, Christa
(2011)
Systemic and hepatic vein galectin-3 are increased in patients with alcoholic liver cirrhosis and negatively correlate with liver function.
Cytokine 55 (3), S. 435-440.
Volltext nicht vorhanden.
2010
Schnitzbauer, Andreas A., Scherer, Marcus N., Rochon, Justine, Sothmann, Johannes, Farkas, Stefan A., Loss, Martin, Geissler, Edward K., Obed, Aiman und Schlitt, Hans J.
(2010)
Study Protocol: A Pilot Study to Determine the Safety and Efficacy of Induction-Therapy, De Novo MPA and Delayed mTOR-Inhibition in Liver Transplant Recipients with Impaired Renal Function. PATRON-Study.
BMC Nephrology 11 (24).
2002
Tange, Stefan, Scherer, Marcus N., Graeb, Christian, Weiss, Thomas S. , Justl, Martin, Frank, Erika, Andrassy, Joachim, Jauch, Karl-Walter und Geissler, Edward K.
(2002)
THE ANTINEOPLASTIC DRUG PACLITAXEL HAS IMMUNOSUPPRESSIVE PROPERTIES THAT CAN EFFECTIVELY PROMOTE ALLOGRAFT SURVIVAL IN A RAT HEART TRANSPLANT MODEL1.
Transplantation 73 (2), S. 216-223.
Volltext nicht vorhanden.
, Justl, Martin, Frank, Erika, Andrassy, Joachim, Jauch, Karl-Walter und Geissler, Edward K.
(2002)
THE ANTINEOPLASTIC DRUG PACLITAXEL HAS IMMUNOSUPPRESSIVE PROPERTIES THAT CAN EFFECTIVELY PROMOTE ALLOGRAFT SURVIVAL IN A RAT HEART TRANSPLANT MODEL1.
Transplantation 73 (2), S. 216-223.
Volltext nicht vorhanden.
Universitätsbibliothek
Publikationsserver
Kontakt:
Publizieren: oa@ur.de
0941 943 -4239 oder -69394
Dissertationen: dissertationen@ur.de
0941 943 -3904
Forschungsdaten: datahub@ur.de
0941 943 -5707